Skip to content

Clinical trials

Phase 3 Peripheral Arterial Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Arterial Disease Phase: Phase 3 Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20122
20131
20151
20201
20221
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Not yet recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
AstraZeneca1
Beijing Northland Biotech. Co., Ltd.1
Bracco Diagnostics, Inc1
Eli Lilly and Company1
Hoffmann-La Roche1
Lee's Pharmaceutical Limited1
Novo Nordisk A/S1
Xuanwu Hospital, Beijing1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Arterial Disease10
Angina Pectoris1
Arterial Occlusive Diseases1
Cardiovascular Diseases1
Coronary Artery Disease1
Coronary Disease1
Diabetes Mellitus, Type 21
Diabetic Angiopathies1
Dyslipidemias1
Heart Diseases1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.